Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






Consumer News Can Mark Cuban’s Costplus Drugs Really Bring Down Drug Costs

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Consumer News Can Mark Cuban’s Costplus Drugs Really Bring Down Drug Costs is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


Consumer News Can Mark Cuban%E2%80%99s Costplus Drugs Really Bring Down Drug Costs | RobinsPost News & Noticias

Direct-to-consumer drug pricing could compete with prescription insurance


A new study offers a glimpse at how direct-to-consumer pharmacy pricing could one day present stiff competition to the private prescription drug insurance model, researchers say. Read More

Mark Cuban gives Trump's proposed direct-to-consumer prescription drugs website a 'B'


The billionaire owner of Cost Plus Drugs is giving the Trump administration's announced website, TrumpRx.gov, a "B" for now. Read More

Mark Cuban Grades Trump's Online Drug Store 'B,' Plans To Give It An 'A' If These Changes Happen: 'Trump Gets All The Credit'


Mark Cuban, the billionaire entrepreneur and investor, has given a cautious “B” grade to President Donald Trump’s new online drug store venture, TrumpRx.gov. Cuban Sees Potential In Trump’s Drug ... Read More

Pharma Pulse: Mark Cuban Disrupts Drug Pricing, AstraZeneca Expands US Manufacturing, and BMS Bets Big on RNA Therapeutics


This episode of Pharma Pulse covers how Mark Cuban’s direct-to-consumer pharmacy is challenging traditional drug pricing models, AstraZeneca’s $4.5 billion investment to expand its Virginia ... Read More

Mark Cuban Would Still Have Dinner With Donald Trump


The billionaire investor campaigned for Kamala Harris, but thinks tech execs have a “moral imperative” to play nice with the president. Why? It’s good business. Read More

Direct-to-consumer pharmacies seem great. But mail-order drugs come with hidden risks. | Opinion


Direct-to-consumer options like Amazon Prime's RXPass and Mark Cuban's Cost Plus Drug Company lack a key patient safety component: Local pharmacists. Read More

Mark Cuban launched Cost Plus Drugs after Republican friends asked for an alternative to Obamacare


What inspired Shark Tank star and billionaire Mark Cuban to launch his pharmaceutical company, Cost Plus Drugs, was conversations with politicians about a contentious topic: Obamacare. "Going back to ... Read More

Mark Cuban says Trump’s new drug platform could succeed if it forces pharma managers to change: ‘If that happens, Trump gets all the credit’


Billionaire venture capitalist Mark Cuban has not shied away from blasting President Donald Trump’s policy decisions, but he said Trump’s latest move just might work. The president announced on ... Read More

Mark Cuban gives Trump's proposed direct-to-consumer prescription drugs website a 'B'


Mark Cuban gave Trump's new drugstore venture a "B," and said it would be good for patients. TrumpRx.gov aims to sell drugs directly to consumers, bypassing Pharmacy Benefit Managers. Cuban questioned ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus